[ Price : $8.95]
FDA warns Little Rock, AR-based 3D Imaging Drug Design and Development about CGMP and listing violations in its production of posi...[ Price : $8.95]
FDA extends the review of Aldeyra Therapeutics NDA resubmission for reproxalap, pushing back a regulatory decision on the investig...[ Price : $8.95]
FDA publishes a draft guidance aimed at increasing the enrollment of females in clinical trials of drugs and medical devices.[ Price : $8.95]
President Trump appoints Yale epidemiologist Harvey Risch to chair the Presidents Cancer Panel, a move that is raising alarm among...[ Price : $8.95]
FDA releases the form FDA-483 with seven observations from an inspection at the Exton, PA-based ProRx outsourcing facility.[ Price : $8.95]
Sanofi says it will not seek FDA approval for tolebrutinib in primary progressive multiple sclerosis after the drug failed to meet...[ Price : $8.95]
FDA says it is removing a long-standing barrier to the use of real-world evidence in regulatory reviews by accepting such data wit...[ Price : $8.95]
FDA posts two final guidances that provide recommendations to help clinical investigators comply with the safety reporting require...